ADRX ADARx Pharmaceuticals, Inc.
NASDAQIndustrialsAs of 2026-10-02
Why ADRX matters now
ADARx Pharmaceuticals, Inc. (ADRX) is a US stock in Industrials. The latest InvestLog snapshot shows $18.25 with -6.60% on the session and $1.87B in market capitalization.
The latest indexable market news headline is "ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering" from GlobeNewsWire.
Latest News
Company Info
Sector
Industrials
Industry
Specialty Business Services
Country
US
Exchange
NASDAQ
Beta
0.00
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.